1 New 6:2 Influenza Virus Reassortant
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 1 New 6:2 Influenza Virus Reassortant, covering 2017-10-04 to 2019-01-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season [Phase 4]